Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers
Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035”
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes
- A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.
- A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.
- A detailed competitiveness analysis of mRNA custom synthesis service providers.
- A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.
- An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.
- A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.
- A detailed product competitiveness analysis of the mRNA synthesis kits.
- Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).
- Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).
- A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.
- An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022
- An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.
- A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Product
- Drug substances (APIs)
- Drug products (FDFs)
- Application Area
- mRNA-based vaccines
- mRNA-based therapeutics
- Therapeutic Area
- Infectious diseases
- Oncological disorders
- Other diseases
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
Key companies covered in the report.
- Aldevron
- APExBIO
- Biomay
- bioSYNTHESIS
- CELLSCRIPT
- eTheRNA
- Eurogentec
- Jena Biosciences
- New England Biolabs
- Thermo Fisher Scientific
- TriLink BioTechnologies
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html
You may also be interested in the following titles:
| Decentralized Clinical Trials / Virtual Clinical Trials Market |
You may also like to learn what our experts are sharing in Roots educational series:
| Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415